scorecardresearch
Monday, August 11, 2025
Support Our Journalism
HomeANI Press ReleasesG.C Chemie Pharmie: Four Decades of Innovation and Trust in Pharmaceuticals and...

G.C Chemie Pharmie: Four Decades of Innovation and Trust in Pharmaceuticals and Nutraceuticals

Follow Us :
Text Size:

India PR Distribution

Mumbai (Maharashtra) [India], June 6: G.C Chemie Pharmie Pvt. Ltd. (GCCPL), a pioneer in India’s pharmaceutical, nutraceutical, functional foods, and biopharmaceutical sectors, proudly celebrates over 44 years of innovation and service excellence. Founded in 1981 by visionary entrepreneur Gautam Shah, GCCPL has evolved into a globally connected and innovation-driven enterprise known for its commitment to trust, transparency, and quality.

What began as an API trading and distribution firm has transformed into a diversified pharmaceutical powerhouse. GCCPL’s impressive timeline of achievements includes:

– 2009/2010: Acquisition of Eagle Chemical Works, establishing its own API manufacturing capabilities

– 2009: Release of its first vaccine, marking a significant milestone in biopharmaceuticals

– 2010/2011: Launch of its P2P division, introducing affordable medicines to the Indian market

-2018: Entry into the sports nutrition space

– 2022: Creation of a preventive healthcare division with a focus on gynecology and orthopedics

– 2023: Establishment of a dedicated vaccine division to expand immunization solutions

Driven by a mission to lead through innovative thinking and technology adoption, GCCPL delivers tailored solutions across pharmaceutical, nutraceutical, and functional food categories. The company continues to differentiate itself through its strong regulatory acumen, cutting-edge R&D, and a global network of manufacturing and distribution partners.

“At GCCPL, innovation is not a buzzword–it’s the foundation of our growth strategy,” said Founder and Chairman Gautam Shah. “We’re proud to be one of India’s few private companies to bring the pneumococcal vaccine to the domestic market, second only to Pfizer.”

Recent product highlights include UC-II®, a patented undenatured type II collagen supplement, and Pylopass™, a breakthrough strain-based probiotic–both showcasing GCCPL’s commitment to introducing clinically backed, innovative health solutions to India.

With a sterling reputation for regulatory compliance, deep market research, and financial integrity–as affirmed by CRISIL’s highest rating A2+ GCCPL stands as a trusted partner for businesses and healthcare providers seeking reliable, next-generation healthcare products.

About G.C Chemie Pharmie Pvt. Ltd.

Founded in 1981, GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global footprint. Known for its reliability, innovation, and commitment to quality, GCCPL offers customized, technology-driven healthcare solutions to meet the evolving needs of today’s market. The company maintains a strong presence in vaccines, preventive care, functional foods, and advanced supplements.

For queries –

Website: www.gccpl.com

(ADVERTORIAL DISCLAIMER: The above press release has been provided by India PR Distribution. ANI will not be responsible in any way for the content of the same)

This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular